Martin L Breitman

Title: Martin L Breitman: Innovator in Endothelial Biology

Introduction

Martin L Breitman is a distinguished inventor based in Willowdale, CA. He has made significant contributions to the field of endothelial biology, holding 2 patents that showcase his innovative research and development.

Latest Patents

Breitman's latest patents include a novel receptor tyrosine kinase protein and its isoforms, which are expressed in cells of the endothelial lineage. This patent discloses methods for identifying ligands capable of binding to the receptor protein, as well as methods for screening agonist or antagonist substances that interact with the protein and a ligand. Another important patent focuses on a novel transcriptional regulatory element that directs gene expression specifically in endothelial lineage cells. This regulatory element can be utilized to target gene expression in these specific cells.

Career Highlights

Martin L Breitman is affiliated with Mount Sinai Hospital Corporation, where he continues to advance research in endothelial biology. His work has implications for understanding vascular biology and developing therapeutic strategies.

Collaborations

Breitman has collaborated with notable colleagues, including Daniel J Dumont and Janet Rossant, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Martin L Breitman exemplifies the spirit of innovation in the field of endothelial biology through his patents and collaborative efforts. His work continues to influence the scientific community and pave the way for future advancements.